HH Biotechnology Holdings Co operates in the Nonresidential building operators sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HH Biotechnology Holdings Co with three other
Real estate operators in Asia:
Great Wall Pan Asia Holdings Ltd
of Hong Kong
sales of 52.83 million Hong Kong Dollars [US$6.80 million]
Trus Y 7 Reit Co Ltd
of South Korea
(7.46 billion Korean Won [US$6.64 million]
Tan Binh Import Export Joint Stock Corp
based in Vietnam
(181.69 billion Dong [US$7.98 million]
HH Biotechnology Holdings Co reported sales of 50.24 million Chinese Renmimbi (US$7.30 million)
December of 2015.
a very small
increase of 2.0%
versus 2014, when the company's sales were 49.28 million Chinese Renmimbi.
This was the fourth straight year of sales growth at HH Biotechnology Holdings Co.
The sales level in 2015 was fairly close to the level five years ago: in 2010, HH Biotechnology Holdings Co had sales
of 51.44 million Chinese Renmimbi.